These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 30785029)
1. Fumarate hydratase deficient renal cell carcinoma: Chromosomal numerical aberration analysis of 12 cases. Pivovarcikova K; Martinek P; Grossmann P; Trpkov K; Alaghehbandan R; Magi-Galluzzi C; Pane Foix M; Condom Mundo E; Berney D; Gill A; Rychly B; Michalova K; Rogala J; Pitra T; Micsik T; Polivka J; Hora M; Tanas Isikci O; Skalova S; Mareckova J; Michal M; Hes O Ann Diagn Pathol; 2019 Apr; 39():63-68. PubMed ID: 30785029 [TBL] [Abstract][Full Text] [Related]
2. Fumarate hydratase deficient renal cell carcinoma and fumarate hydratase deficient-like renal cell carcinoma: Morphologic comparative study of 23 genetically tested cases. Pivovarčíková K; Martínek P; Trpkov K; Alaghehbandan R; Magi-Galluzzi C; Mundo EC; Berney D; Suster S; Gill A; Rychlý B; Michalová K; Pitra T; Hora M; Michal M; Hes O Cesk Patol; 2019; 55(4):244-249. PubMed ID: 31842557 [TBL] [Abstract][Full Text] [Related]
3. SWI/SNF protein expression status in fumarate hydratase-deficient renal cell carcinoma: immunohistochemical analysis of 32 tumors from 28 patients. Agaimy A; Amin MB; Gill AJ; Popp B; Reis A; Berney DM; Magi-Galluzzi C; Sibony M; Smith SC; Suster S; Trpkov K; Hes O; Hartmann A Hum Pathol; 2018 Jul; 77():139-146. PubMed ID: 29689242 [TBL] [Abstract][Full Text] [Related]
4. Array comparative genomic hybridization identifies a distinct DNA copy number profile in renal cell cancer associated with hereditary leiomyomatosis and renal cell cancer. Koski TA; Lehtonen HJ; Jee KJ; Ninomiya S; Joosse SA; Vahteristo P; Kiuru M; Karhu A; Sammalkorpi H; Vanharanta S; Lehtonen R; Edgren H; Nederlof PM; Hietala M; Aittomäki K; Herva R; Knuutila S; Aaltonen LA; Launonen V Genes Chromosomes Cancer; 2009 Jul; 48(7):544-51. PubMed ID: 19373782 [TBL] [Abstract][Full Text] [Related]
5. Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status. Bardella C; El-Bahrawy M; Frizzell N; Adam J; Ternette N; Hatipoglu E; Howarth K; O'Flaherty L; Roberts I; Turner G; Taylor J; Giaslakiotis K; Macaulay VM; Harris AL; Chandra A; Lehtonen HJ; Launonen V; Aaltonen LA; Pugh CW; Mihai R; Trudgian D; Kessler B; Baynes JW; Ratcliffe PJ; Tomlinson IP; Pollard PJ J Pathol; 2011 Sep; 225(1):4-11. PubMed ID: 21630274 [TBL] [Abstract][Full Text] [Related]
6. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase-deficient Renal Cell Carcinoma. Ohe C; Smith SC; Sirohi D; Divatia M; de Peralta-Venturina M; Paner GP; Agaimy A; Amin MB; Argani P; Chen YB; Cheng L; Colecchia M; Compérat E; Werneck da Cunha I; Epstein JI; Gill AJ; Hes O; Hirsch MS; Jochum W; Kunju LP; Maclean F; Magi-Galluzzi C; McKenney JK; Mehra R; Nesi G; Osunkoya AO; Picken MM; Rao P; Reuter VE; de Oliveira Salles PG; Schultz L; Tickoo SK; Tomlins SA; Trpkov K; Amin MB Am J Surg Pathol; 2018 Mar; 42(3):279-292. PubMed ID: 29309300 [TBL] [Abstract][Full Text] [Related]
7. A Clinicopathological and Molecular Analysis of Fumarate Hydratase (FH)-deficient Renal Cell Carcinomas with Heterogeneous Loss of FH Expression. Anderson WJ; Tsai HK; Sholl LM; Hirsch MS Int J Surg Pathol; 2022 Sep; 30(6):606-615. PubMed ID: 35048731 [No Abstract] [Full Text] [Related]
8. Mucinous spindle and tubular renal cell carcinoma: analysis of chromosomal aberration pattern of low-grade, high-grade, and overlapping morphologic variant with papillary renal cell carcinoma. Peckova K; Martinek P; Sperga M; Montiel DP; Daum O; Rotterova P; Kalusová K; Hora M; Pivovarcikova K; Rychly B; Vranic S; Davidson W; Vodicka J; Dubová M; Michal M; Hes O Ann Diagn Pathol; 2015 Aug; 19(4):226-31. PubMed ID: 26009022 [TBL] [Abstract][Full Text] [Related]
9. Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome. Trpkov K; Hes O; Agaimy A; Bonert M; Martinek P; Magi-Galluzzi C; Kristiansen G; Lüders C; Nesi G; Compérat E; Sibony M; Berney DM; Mehra R; Brimo F; Hartmann A; Husain A; Frizzell N; Hills K; Maclean F; Srinivasan B; Gill AJ Am J Surg Pathol; 2016 Jul; 40(7):865-75. PubMed ID: 26900816 [TBL] [Abstract][Full Text] [Related]
10. Conventional renal cancer in a patient with fumarate hydratase mutation. Lehtonen HJ; Blanco I; Piulats JM; Herva R; Launonen V; Aaltonen LA Hum Pathol; 2007 May; 38(5):793-6. PubMed ID: 17270241 [TBL] [Abstract][Full Text] [Related]
11. Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma. Kopp RP; Stratton KL; Glogowski E; Schrader KA; Rau-Murthy R; Russo P; Coleman JA; Offit K Cancer; 2017 Jul; 123(13):2452-2458. PubMed ID: 28171700 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma. Vocke CD; Ricketts CJ; Merino MJ; Srinivasan R; Metwalli AR; Middelton LA; Peterson J; Yang Y; Linehan WM Genes Chromosomes Cancer; 2017 Jun; 56(6):484-492. PubMed ID: 28196407 [TBL] [Abstract][Full Text] [Related]
13. Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas. Yoo A; Tang C; Zucker M; Fitzgerald K; DiNatale RG; Rappold PM; Weiss K; Freeman B; Lee CH; Schultz N; Motzer R; Russo P; Coleman J; Reuter VE; Chen YB; Carlo MI; Gill AJ; Kotecha RR; Ari Hakimi A; Reznik E Eur Urol Focus; 2022 Sep; 8(5):1278-1288. PubMed ID: 35288096 [TBL] [Abstract][Full Text] [Related]
14. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Merino MJ; Torres-Cabala C; Pinto P; Linehan WM Am J Surg Pathol; 2007 Oct; 31(10):1578-85. PubMed ID: 17895761 [TBL] [Abstract][Full Text] [Related]
15. Fumaratehydratase-deficient renal cell carcinoma: a clinicopathological and molecular study of 13 cases. Pan X; Zhang M; Yao J; Zeng H; Nie L; Gong J; Chen X; Xu M; Zhou Q; Chen N J Clin Pathol; 2019 Nov; 72(11):748-754. PubMed ID: 31262952 [TBL] [Abstract][Full Text] [Related]
16. Cascade Fumarate Hydratase mutation screening allows early detection of kidney tumour: a case report. Chan MMY; Barnicoat A; Mumtaz F; Aitchison M; Side L; Brittain H; Bates AWH; Gale DP BMC Med Genet; 2017 Jul; 18(1):79. PubMed ID: 28747166 [TBL] [Abstract][Full Text] [Related]
17. A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients. Lau HD; Chan E; Fan AC; Kunder CA; Williamson SR; Zhou M; Idrees MT; Maclean FM; Gill AJ; Kao CS Am J Surg Pathol; 2020 Jan; 44(1):98-110. PubMed ID: 31524643 [TBL] [Abstract][Full Text] [Related]
18. Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report. Kamai T; Abe H; Arai K; Murakami S; Sakamoto S; Kaji Y; Yoshida KI BMC Cancer; 2016 Mar; 16():232. PubMed ID: 26983443 [TBL] [Abstract][Full Text] [Related]
19. Fumarate Hydratase-deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings. Harrison WJ; Andrici J; Maclean F; Madadi-Ghahan R; Farzin M; Sioson L; Toon CW; Clarkson A; Watson N; Pickett J; Field M; Crook A; Tucker K; Goodwin A; Anderson L; Srinivasan B; Grossmann P; Martinek P; Ondič O; Hes O; Trpkov K; Clifton-Bligh RJ; Dwight T; Gill AJ Am J Surg Pathol; 2016 May; 40(5):599-607. PubMed ID: 26574848 [TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma]. Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864 [No Abstract] [Full Text] [Related] [Next] [New Search]